The company “Nanolek” factory in the Kirov region has established the production of one of the drugs for the treatment of coronavirus infection of hydroxychloroquine. Currently, hydroxychloroquine is included in the treatment protocols in the interim Ministry of health recommendations for the prevention, diagnosis and treatment of new coronavirus infection.
The first batch of this drug was shipped to medical institutions in various regions of the Russian Federation.
“We hope that the release of the drug in our production will reduce the deficit and to cover the demand for this drug, because it retains the need for patients suffering from malaria and rheumatoid arthritis who are on therapy with this drug for many years”, – said Mikhail Nekrasov, CEO of NANOLEK. Nekrasov explained that “Nanolek” started the development of hydroxychloroquine in 2013 in conjunction with the company “BIOCOM” in the framework of the state contract.